Company Overview
| Stock Name | NC Healthcare |
|---|---|
| Stock Code | 01518 |
| Company Full Name | To be extracted |
| Industry | Healthcare |
| Principal Activities | 我們是北京領先的私立兒科醫療服務提供者,旗下以「新世紀醫療」品牌經營三間醫療機構,提供兒科及婦產科專科服務,並於二零一五年十二月開始提供醫院諮詢服務。 |
| Listing Date | 2017-01-18 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | To be extracted |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 北京市西城區南禮士路56號 |
| Business Address (Hong Kong) | 香港銅鑼灣勿地臣街1號時代廣場二座36樓 |
| Place of Incorporation | To be extracted |
| Listing Method | To be extracted |
| Listing Board | Main Board |
| Website | www.ncich.com.cn |
| Share Registrar | 香港中央證券登記有限公司 (Computershare Hong Kong Investor Services Limited) |
| Registrar Contact | (852)2862 8628 |
| A-Share/US Dual Listing | No |
Offering Information
| Offering Mechanism | Mechanism A |
|---|---|
| Offer Price | HK$ 7.36 / shares |
| Offer Price Range | To be extracted |
| Lot Size | To be extracted |
| Entry Threshold | To be extracted |
| Par Value | To be extracted |
| Offer Period | 2016-12-30 to 2017-01-11 |
| Global Offering Shares | 120,000,000 shares |
| HK Public Offer Shares (Initial) | 12,000,000 shares (10.0%) |
| Public Offer Lots (Initial) | To be extracted |
| International Placing Shares (Initial) | 108,000,000 shares (90.0%) |
| Offer Ratio | ~10.0% |
| Total Shares Post-IPO | 480,000,000 shares |
| Greenshoe (Over-allotment Option) | Yes |
| Stabilizing Manager (Greenshoe) | To be extracted |
| Cornerstone Share | 16.0% |
| Clawback Tiers | To be extracted |
| Reallocation Option | Yes |
| Total Global Offering Size | HK$ 883,200,000 |
Stock Connect Inclusion Analysis
| 26Q4 Regular Review | |
| Inclusion Pathway | Regular Path |
|---|---|
| Avg Daily HK Mkt Cap | HK$ 145.5M |
| Est. Threshold | HK$ 9.71B |
| Analysis Result | HK market cap below threshold, need +6574% |
Valuation & Financials
| Market Cap (at Offer Price) | To be extracted |
|---|---|
| Pre-IPO Valuation (Last Round) | Not disclosed |
| P/E Ratio | Not disclosed |
| Profit/Loss Status | 盈利約人民幣67.2百萬元 |
| Period-End Cash Balance | To be extracted |
| Listing Expenses | To be extracted |
| Listing Expenses / Funds Raised | To be extracted |
| Total Pre-IPO Investment | To be extracted |
Financial Data
Unit:
'000
RMB
Income Statement
| Item | 2013 | 2014 | 2015 | 2016-09 |
|---|---|---|---|---|
| Revenue | 238,770 | 249,013 | 258,196 | 340,026 |
| Cost of sales | -88,981 | -105,118 | -117,686 | -176,414 |
| Gross profit | 149,789 | 143,895 | 140,510 | 163,612 |
| Other income and gains, net | 27 | 136 | 125 | -17,927 |
| Selling and distribution expenses | -7,272 | -11,278 | -10,612 | -13,811 |
| Administrative expenses | -32,883 | -34,702 | -38,312 | -63,935 |
| Operating profit | 109,661 | 98,051 | 91,711 | 67,939 |
| Net finance costs | -1,087 | -2,647 | -273 | 961 |
| Profit before tax | 110,748 | 100,698 | 91,984 | 66,978 |
| Income tax expense | -28,038 | -26,383 | -24,789 | -23,840 |
| Profit for the year | 82,710 | 74,315 | 67,195 | 43,138 |
| Profit attributable to owners | 53,566 | 46,705 | 40,903 | 19,193 |
Balance Sheet
| Item | 2013 | 2014 | 2015 | 2016-09 |
|---|---|---|---|---|
| Cash and cash equivalents | 128,959 | 120,639 | 81,231 | 151,871 |
| Trade and bills receivables | 6,971 | 6,567 | 12,193 | 7,987 |
| Inventories | 4,783 | 3,320 | 4,625 | 6,281 |
| Total current assets | 146,636 | 135,094 | 126,112 | 206,522 |
| Total assets | 166,636 | 155,430 | 532,063 | 600,530 |
| Total current liabilities | 48,638 | 57,968 | 165,507 | 167,913 |
| Total liabilities | 48,638 | 57,968 | 564,457 | 532,290 |
| Total equity | 117,998 | 97,462 | -32,394 | 68,240 |
| Equity attributable to owners | 79,786 | 63,088 | -43,501 | 27,285 |
| Interest-bearing borrowings | 0 | 0 | 30,000 | 24,990 |
Cash Flow Statement
| Item | 2013 | 2014 | 2015 | 2016-09 |
|---|---|---|---|---|
| Net cash from operating activities | 87,705 | 84,560 | 79,071 | 72,112 |
| Net cash from investing activities | -4,646 | -3,029 | -19,122 | 7,215 |
| Net cash from financing activities | -80,091 | -89,851 | -99,357 | -8,687 |
| Net increase in cash | 2,968 | -8,320 | -39,408 | 70,640 |
| Purchase of PP&E | -2,854 | -3,248 | -5,694 | -10,552 |
Income Statement
Balance Sheet
Cash Flow Statement
Source: Accountants' Report and Audited Consolidated Financial Statements
| First Day Close | HK$ 7.35 |
|---|---|
| First Day Open | HK$ 7.5 |
| First Day Change | -0.14% |
| First Day Volume | 12546500.0 |
| First Day Turnover | 91943300.0 |
| Use of Proceeds | 1、39.4百萬港元(相當于所得款項凈額的5.0%)將用于在北京興建一座遠程醫療診斷中心;
2、39.4百萬港元(相當于所得款項凈額的5.0%)將用于翻新及提升我們于北京的一間手術中心;
3、157.7百萬港元(相當于所得款項凈額的20.0%)將用于在北京開設一家新醫院以提供專業兒科及婦產科服務以及在北京開設兩家診所以主要提供門診服務;
4、157.7百萬港元(相當于所得款項凈額的20.0%)將用于在北京以外的一線城市開設一間新醫院及兩間診所;
5、315.5百萬港元(相當于所得款項凈額的40.0%)將用于收購一線城市(包括北京)的一間醫院及五間診所;
6、78.9百萬港元(相當于所得款項凈額的10.0%)將用作營運資金及其他一般公司用途。 |
Underwriting Syndicate
Joint Sponsors (2)
Overall Coordinators (2)
Joint Bookrunners (4)
Joint Lead Managers (4)
Cornerstone Investors
| # | Investor Name | Investment Amount | Shares Subscribed | % of Offer Shares | % of Total Shares | Lock-up Period | Est. Unlock Date |
|---|---|---|---|---|---|---|---|
| 1 | CNCB (Cayman) NCH LP | 175,904,000 HKD | — | 4.98% | — | 6 months | 2017-07-18 |
| 2 | Janchor Partners Pan-Asian Master Fund | 155,093,600 HKD | — | 4.39% | — | 6 months | 2017-07-18 |
| 3 | 中国人寿再保险有限责任公司 | 232,642,240 HKD | — | 6.59% | — | 6 months | 2017-07-18 |
Directors & Management
| Position | Chinese name | English Name |
|---|---|---|
| Chairman | Jason ZHOU | — |
| Company Secretary | 賈曉鋒、黃秀萍 | — |
No director data available.
Major Shareholders
| Major Shareholders & Holdings | Zhou先生持有45.0%、梁女士持有12.0%、鼎暉孚紀持有6.2%、鼎暉孚怡持有6.2%、安怡和康持有6.6%、甘鋒女士持有5.0%、國禾嘉華持有4.1%。 |
|---|




